:: 25 June 2009 ::
Inotek Pharmaceuticals' Novel Glaucoma Candidate, INO-8875, Significantly Reduces Intraocular Pressure in Phase 1/2 Study
:: read full press release ::

:: 6 May 2009 ::
Inotek Pharmaceuticals Presents Preclinical Data in Support of Novel Glaucoma Candidate, INO-8875 at ARVO
:: read full press release ::

:: 28 Apr 2009 ::
Inotek Pharmaceuticals' Novel Glaucoma Candidate, INO-8875, Selected for Presentation at the ARVO 2009 Annual Meeting
:: read full press release ::

:: 13 Nov 2008 ::
Patents Issue for Inotek Pharmaceuticals’ Lead Clinical Candidates in Glaucoma and Contrast-Induced Nephropathy
:: read full press release ::

:: 1 Oct 2008 ::
Inotek Appoints Paul G. Howes as President and CEO
:: read full press release ::